Literature DB >> 15845552

Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases.

Kubata Bruno Kilunga1, Tsuyoshi Inoue, Yousuke Okano, Zakayi Kabututu, Samuel K Martin, Michael Lazarus, Michael Duszenko, Yuichi Sumii, Yukiko Kusakari, Hiroyoshi Matsumura, Yasushi Kai, Shigeru Sugiyama, Kouji Inaka, Takashi Inui, Yoshihiro Urade.   

Abstract

Trypanosoma brucei prostaglandin F2alpha synthase is an aldo-ketoreductase that catalyzes the reduction of prostaglandin H2 to PGF2alpha in addition to that of 9,10-phenanthrenequinone. We report the crystal structure of TbPGFS.NADP+.citrate at 2.1 angstroms resolution. TbPGFS adopts a parallel (alpha/beta)8-barrel fold lacking the protrudent loops and possesses a hydrophobic core active site that contains a catalytic tetrad of tyrosine, lysine, histidine, and aspartate, which is highly conserved among AKRs. Site-directed mutagenesis of the catalytic tetrad residues revealed that a dyad of Lys77 and His110, and a triad of Tyr52, Lys77, and His110 are essential for the reduction of PGH2 and 9,10-PQ, respectively. Structural and kinetic analysis revealed that His110, acts as the general acid catalyst for PGH2 reduction and that Lys77 facilitates His110 protonation through a water molecule, while exerting an electrostatic repulsion against His110 that maintains the spatial arrangement which allows the formation of a hydrogen bond between His110 and C11 that carbonyl of PGH2. We also show Tyr52 acts as the general acid catalyst for 9,10-PQ reduction, and thus we not only elucidate the catalytic mechanism of a PGH2 reductase but also provide an insight into the catalytic specificity of AKRs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845552     DOI: 10.1074/jbc.M413884200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis.

Authors:  Karen G Rothberg; Dara L Burdette; Joy Pfannstiel; Neal Jetton; Rashmi Singh; Larry Ruben
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

Review 3.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 4.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

5.  Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F2α synthase, AKR1B3.

Authors:  Yasuhide Takashima; Seika Hatanaka; Eiichi Mizohata; Nanae Nagata; Yoshifumi Fukunishi; Hiroyoshi Matsumura; Yoshihiro Urade; Tsuyoshi Inoue
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-30

6.  Structural and biochemical analyses of YvgN and YtbE from Bacillus subtilis.

Authors:  Jian Lei; Yan-Feng Zhou; Lan-Fen Li; Xiao-Dong Su
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

7.  Structure of the inhibitor complex of old yellow enzyme from Trypanosoma cruzi.

Authors:  Keishi Yamaguchi; Naoki Okamoto; Keiji Tokuoka; Shigeru Sugiyama; Nahoko Uchiyama; Hiroyoshi Matsumura; Koji Inaka; Yoshihiro Urade; Tsuyoshi Inoue
Journal:  J Synchrotron Radiat       Date:  2010-11-12       Impact factor: 2.616

8.  A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism.

Authors:  Adam J Roberts; Joanne Dunne; Paul Scullion; Suzanne Norval; Alan H Fairlamb
Journal:  Biochem J       Date:  2018-08-30       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.